Close menu




chemicals

Photo credits: pixabay.com

Commented by Stefan Feulner on July 31st, 2023 | 09:50 CEST

BASF, Cantourage Group, Palantir - Now the analysts speak out

  • Cannabis
  • Software
  • chemicals

Currently, it is high noon for the release of first-half 2023 earnings. Despite all the uncertainties regarding geopolitical and fiscal policy, the majority of companies surprised positively. As a result, the Dow Jones, DAX, Nasdaq and others were able to climb to new highs for the year. Analysts also see further upside potential for many companies, which could accelerate the rally in the coming weeks.

Read

Commented by Nico Popp on July 17th, 2023 | 07:55 CEST

The hour of the problem solvers: BASF, BYD, dynaCERT

  • Hydrogen
  • greenhydrogen
  • Electromobility
  • chemicals

The transformation of industry is not proceeding smoothly. The best example is the recent profit warning from the chemical group BASF. Earlier, Lanxess and the Swiss company Clariant also revised their forecasts. The reason: The economic recovery in the second half of the year is likely to be slower than previously assumed. When the global economy falters, chemical companies are among the first to feel the effects - they produce many important basic materials and are linked to many other industries. Although BASF already sees demand for basic chemicals at a low level that is not expected to decline further, there are no signs of any recovery momentum either.

Read

Commented by Fabian Lorenz on July 14th, 2023 | 07:50 CEST

Bulls at the controls: Nel, Barrick Gold, Viva Gold! What about BASF?

  • Mining
  • Gold
  • chemicals
  • Copper

Low inflation in the US has given new impetus to the bulls. Not only are growth stocks benefiting from the hope that the interest rate cycle is coming to an end, but also gold. Thus, the gold price reacted on Wednesday by jumping to over USD 1,960 per troy ounce. Top-tier gold stocks such as Barrick also responded positively. Exploration companies have significant catch-up potential, including Viva Gold. The Company is favorably valued and has again reported positive drill results. The fact that the interest rate cycle is nearing its end is also evident in the chemical industry. Most recently, BASF issued a warning, and there are sell recommendations. On the other hand, there are buy recommendations for the Nel share.

Read

Commented by Stefan Feulner on July 14th, 2023 | 07:30 CEST

Plug Power, First Phosphate, BASF - Turnaround in sight

  • Mining
  • phosphate
  • chemicals
  • renewableenergies

After a sharp correction that lasted for months, companies in the renewable energy sector are forming a sustainable bottom. In recent trading days, the prices of water, wind and solar shares have moved significantly away from their lows. From a fundamental perspective, the future appears rosy, which could present a favourable long-term entry opportunity.

Read

Commented by Nico Popp on June 22nd, 2023 | 09:05 CEST

Isolation and e-car crash - A new China shock for markets? BASF, NIO, Power Nickel

  • Mining
  • Nickel
  • chemicals

It was a profit warning with a signal effect: Lanxess shares plunged on Tuesday after a gloomy outlook. The BASF share also came under pressure as a result. Once again, developments around China are causing concern. While the major economies are increasingly isolating themselves and relying on autarky and protectionism, the collateral damage is increasing. But there are also profiteers. We shed light on the opportunities and risks.

Read

Commented by Stefan Feulner on June 21st, 2023 | 07:20 CEST

Lanxess, Smartbroker, Helma Eigenheimbau - Great opportunities in uncertain times

  • Brokerage
  • Stockmarket
  • chemicals
  • Real Estate

The stock market is still defying negative omens such as recession, the strict monetary policy of the central banks and escalating geopolitical risks. Just a few days ago, for example, the German leading index DAX recorded a new all-time high. However, the negative voices concerning significant global stock market setbacks are increasing. Nevertheless, some companies have the potential to significantly outperform the market due to special situations.

Read

Commented by Fabian Lorenz on June 7th, 2023 | 08:00 CEST

Commodity shares with price potential: Bayer, K+S, and Almonty Industries in the analyst check

  • Mining
  • Tungsten
  • chemicals
  • fertilizer

There are no signs of a deep recession in the US at the moment, which is positive for commodity prices and the corresponding companies. What do analysts say? They see a price potential of over 170% for tungsten producer Almonty Industries. With the commissioning of the flagship mine in South Korea, revenues and profits should increase strongly from 2024. After K+S earned brilliantly last year, there is a lack of positive impulses this year. Several analysts have spoken out. Can the DAX-listed company make gains again? At Bayer, the euphoria surrounding the change in the board of directors has faded, and the share price is almost back to where it was at the beginning of the year. But analysts see significant upside potential.

Read

Commented by Nico Popp on May 18th, 2023 | 09:30 CEST

Climate protection as an investment: BASF, Commerzbank, GoviEX Uranium

  • Mining
  • Uranium
  • Investments
  • chemicals

Fewer CO2 emissions, more climate protection. Every DAX-listed company is committed to more sustainability in some form or another. But what is the truth of these promises? And are the supposed climate shares a sustainable investment at all? We do the check and take a detailed look at three exciting stocks from different sectors and regions.

Read

Commented by Fabian Lorenz on May 4th, 2023 | 08:10 CEST

Buy or sell? TUI, BASF and Defence Therapeutics

  • Biotechnology
  • travel
  • chemicals

BASF share a buy or sell? Analyst opinions on the chemical giant diverge widely. The DAX-listed company has just reported quarterly figures, but it did not provide clarity about the prospects. However, some speculate on a forecast increase. Analysts have not commented on TUI for quite some time. After the turbulence surrounding the capital increase, new impulses are being sought, perhaps through a deal with the German government? There is plenty of impetus for rising prices at Defence Therapeutics. The biotech high-flyer of the past months is increasingly positioning itself as a partner to BioNTech, Moderna and Co - and perhaps even a takeover candidate.

Read

Commented by Nico Popp on March 29th, 2023 | 08:15 CEST

Market failure! Highs and lows at BASF, Myriad Uranium, Vonovia

  • Mining
  • Uranium
  • chemicals
  • RealEstate

We all know efficient markets from the textbook. There, buyers and sellers always come together - and in the end, there is no apple left over. In reality, markets are highly complex and are sometimes dependent on external factors that can change everything overnight. Today we look at BASF's business in China, the real estate market and the emerging market for uranium.

Read